Boston Scientific kicks off migraine study; Cardium hauls in $1.7M;

 @FierceMedDev: Stryker's sales up 5%, but recalls swallow profits. Report | Follow @FierceMedDev

 @MarkHFierce: ArthroCare's ex-CEO and former CFO both face multiple charges in a $400M fraud scheme. ICYMI yesterday | Follow @MarkHFierce

 @DamianFierce: A House group has introduced the FDA SOS Act, designed to save user fees from sequester cuts. Report | Follow @DamianFierce

> Boston Scientific ($BSX) has kicked off a trial to see how well its Precision nerve-stimulation system can treat chronic migraines. News

> RTI Biologics has completed its $130 million purchase of Pharos Capital Group's stake in Pioneer Surgical Technology, which distributes and makes medical device implants. Item

> Cardium Therapeutics ($CXM) has raised $1.7 million to round out a $4 million preferred stock financing. Item

> Low-dose CT scans for patients at high risk for lung cancer are more effective at preventing deaths from the disease than scanning patients at low risk, according to a wide-ranging new analysis. Story

> A new self-expanding stent has shown promise as a treatment of long lesions of the superficial femoral artery in patients with atherosclerotic disease. Story

> Cook Medical is debuting new tissue-repair technology to help accelerate healing after nasal and sinus mucosal surgery. Item

> Elekta won a CE marking for its new 4-D monitoring system, which is designed to monitor the prostate during radiation treatment. Item

> ResMed ($RMD) has succeeded in a patent fight against Taiwanese manufacturer APEX Medical, shutting down the importation and sale of infringing APEX respiratory devices. More

Biotech News

 @FierceBiotech: $1.3B VC cash surge buoys biotech as analysts point to a rebound. More | Special Report: The Top 15 Biotech VC firms | Follow @FierceBiotech

 @JohnCFierce: Novartis buries a PhIII kidney cancer failure behind Q2 successes. News | Follow @JohnCFierce

 @RyanMFierce: After Nobel Prize, Japan wants to take lead in iPSC therapy with approval of clinical trial. Article | Follow @RyanMFierce

 @EmilyMFierce: The latest at Revalesio drug alters Alzheimer's progression in animal model. Story | Follow @EmilyMFierce

> Japan green-lights trial for adult stem cell therapy for eye disease. More

> U.K. pharma group's cannabis-based diabetes drug sparks insulin output. More

> Report: Pfizer backs off Onyx bid as price gets too rich. Article

Pharma News

 @FiercePharma: Peace treaty in Vivus proxy war: $VVUS hands board control to rebels, with new CEO Zook poised to step in. Report | Follow @FiercePharma

 @EricPFierce: From ABC's appointment of Jenny McCarthy sparks media furor. Story | Follow @EricPFierce

 @CarlyHFierce: Vivus, First Manhattan reach agreement - Wilson out as CEO and 6 FMC candidates join board. Article | Follow @CarlyHFierce

> GSK sends contingent to China, even as country prevents one exec from leaving. Article

> Bristol-Myers Squibb moving 575 jobs to Tampa. Report

> J&J's Simponi approved for RA as it heads for blockbuster stratosphere. Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.